Hi, Tigers!
Welcome to Daily Discussion! This is the place for you to share your trading ideas and win coins!
[Rewards]
We will reward you with 50 Tiger Coins when you share your knowledge about stocks and markets here, depending on quality and originality.
[Winners Announcement:17 Apr]
1.Here are the 3 Tigers whose post has the best quality & interaction yesterday: @nerdbull1669 @JC888 @yourcelesttyy
Congratulations on being offered 50 Tiger Coins!
Verizon (VZ) Cost Management Amid Market Recession Fears
US Market closes High pre Good Friday? Errh...
Stocks to Watch Today (April 17, 2025): Tech Tanks, Hertz SurgesβWhereβs the Opportunity?
2.Here are the stocks mentioned by the above Tigers: $Verizon(VZ)$ $Dow Jones(.DJI)$ $S&P 500(.SPX)$ $NASDAQ(.IXIC)$ $NVIDIA(NVDA)$ $Advanced Micro Devices(AMD)$ (Not investment advice)
And let's congratulate these Tigers for winning 5-40 Coins:@εζη― @Mrzorro @Twelve_E
Last night, $Taiwan Semiconductor Manufacturing(TSM)$ up 0.05%. There were 6 Tigers that answered correctly and successfully shared 1000 Tiger coins, with each Tiger getting 167 Tiger coins as a reward! Tiger coins have been issued! CongratulationsοΌ
Below are Today's Key Takeaways.
Top News Move the Market
The S&P 500 climbed 0.13% to end the session at 5,282.70 points. The Nasdaq declined 0.13% to 16,286.45 points, while the Dow Jones Industrial Average declined 1.33% to 39,142.23 points.
Hertz Global - Hertz skyrocketed 44.3%, building on the previous sessionβs 56% surge. The gains came after Bill Ackmanβs Pershing Square disclosed a 4% stake in the rental-car company.
UnitedHealth - UnitedHealth cratered 22.4% after first-quarter adjusted earnings at the giant health insurer missed analystsβ expectations and the company cut its 2025 guidance. The stock had its worst session in 25 years, according to Dow Jones Market Data. UnitedHealth expects adjusted earnings in 2025 in the range of $26 to $26.50 a share, down from its previous guidance of $29.50 to $30 a share, provided in December.
Eli Lilly - Eli Lilly soared 14.3% after the pharmaceutical company said it successfully completed a Phase 3 trial for its new orforglipron pill. Orforglipron is a GLP-1 receptor agonist that works similarly to diabetes treatments like Ozempic. Data collected during the trial showed the pill was as safe as injectable GLP-1 medicines currently on the market.
Trump Says He Is Reluctant to Keep Raising Tariffs on China
Tiger Community TOP10 Tickers
βFor The Daily Most Active Stocks in S&P 500 & The Top 10 Popular Stcocks on WallStreetBets please turn to @TigerObserver
All right, here is all the market information we would like to share with youοΌ
What news/movements are worth noting in the market today? Any stocks to watch?
Do you have any trading plans?
Is there anything you would like to share about your trades today?
[How to participate]
Directly post content in the comments section (Note: Make sure the "Also Post" button is ticked!)
Share your ideas on the trading opportunities or the market trends, and you will win coins!
Stay safe and good luck with your investing!
Comments